Standout Papers

Markers of Inflammation and Cardiovascular Disease 2000 2026 2008 2017 5.0k
  1. Markers of Inflammation and Cardiovascular Disease (2003)
    Thomas A. Pearson, George A. Mensah et al. Circulation
  2. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update (2006)
    Sidney C. Smith, Jerilyn K. Allen et al. Circulation
  3. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update (2002)
    Thomas A. Pearson, Steven N. Blair et al. Circulation
  4. Guidelines for the Primary Prevention of Stroke (2010)
    Larry B. Goldstein, Cheryl Bushnell et al. Stroke
  5. Trends and Disparities in Coronary Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States (2000)
    Richard Cooper, Jeffrey A. Cutler et al. Circulation
  6. How to Interpret a Genome-wide Association Study (2008)
    Thomas A. Pearson JAMA
  7. Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. (2011)
    Larry B. Goldstein, Cheryl Bushnell et al. Stroke
  8. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update (2001)
    Sidney C. Smith, Steven N. Blair et al. Journal of the American College of Cardiology
  9. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update (2006)
    Sidney C. Smith, Jerilyn K. Allen et al. Journal of the American College of Cardiology
  10. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial (2018)
    J. Michael Gaziano, Carlos Brotons et al. The Lancet

Immediate Impact

2 from Science/Nature 85 standout
Sub-graph 1 of 19

Citing Papers

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
2020 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout

Works of Thomas A. Pearson being referenced

Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians
2008
Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations
2005

Author Peers

Author Last Decade Papers Cites
Thomas A. Pearson 9708 6743 4840 4990 289 27.1k
Sonia S. Anand 9844 5967 4410 3048 358 25.6k
Richard Cooper 10574 4673 7785 3592 349 30.0k
Moysés Szklo 10050 4168 4634 3753 384 30.1k
Lars Wilhelmsen 12388 8819 7940 3499 390 31.1k
Samuel S. Gidding 9673 4927 3314 3003 342 21.1k
James D. Neaton 12140 6009 8541 3747 229 31.0k
Lisa Sullivan 8462 4096 6737 5905 381 34.0k
Erin D. Michos 11089 5644 5084 2732 671 28.7k
Donna K. Arnett 14275 5312 4835 3473 493 34.0k
Shah Ebrahim 8743 3650 3620 5881 386 34.8k

All Works

Loading papers...

Rankless by CCL
2026